title: Multiple pituitary hormone deficiency: management of puberty for optimal auxological results.
abstract: The overview in this paper focuses on ways of achieving optimal auxological results in puberty, principally in idiopathic and congenital multiple pituitary hormone deficiency (MPHD), suggested by the co-authors. We agreed that diagnosing gonadotrophin insufficiency/deficiency is difficult in young children and should be repeated in late prepuberty, but a firm diagnosis of MPHD helps avoid endocrine re-testing at the end of growth. The hypothalamic-pituitary axis must be reassessed periodically in evolving endocrinopathies, though current practice varies widely. Optimum age to induce puberty is 11-12 years in girls and 13-14 boys, and sex steroids are the preferred agents. Short-course testosterone to increase micropenis size is advantageous, but inducing early testicular maturation is not known to improve later fertility. There is also little evidence for increasing the dose of GH during puberty, though therapy should continue to final height, and possibly until peak bone mass is achieved. Delaying puberty is an option in septo-optic dysplasia, and minimising the dose of hydrocortisone is crucial in treating ACTH/cortisol insufficiency. Many unresolved questions remain in this difficult area.
authors.affiliation: Department of Paediatric Endocrinology, Institute of Child Health, London, UK. R.Stanhope@ich.ucl.ac.uk
authors.forename: R
authors.initials: R
authors.lastname: Stanhope
authors.forename: F
authors.initials: F
authors.lastname: De Luca
authors.forename: H A
authors.initials: HA
authors.lastname: Delemarre-Van de Waal
authors.forename: A
authors.initials: A
authors.lastname: Liotta
authors.forename: E
authors.initials: E
authors.lastname: Norjavaara
authors.forename: A
authors.initials: A
authors.lastname: Salvatoni
authors.forename: F
authors.initials: F
authors.lastname: Wu
mesh_terms: D000293:Adolescent; D002648:Child; D005260:Female; D006130:Growth Disorders / Q000188:drug therapy* / Q000209:etiology*; D013006:Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010907:Pituitary Hormones / Q000172:deficiency*; D011627:Puberty / Q000187:drug effects / Q000502:physiology*
chemical_list: D010907:Pituitary Hormones; D013006:Growth Hormone